Clinical Scorecard: HHS Allocates $51 Million to Enhance Dental Services for Children with Neurodevelopmental Disorders
At a Glance
Category
Detail
Condition
Clinical topic addressed by the source article: HHS Allocates $51 Million to Enhance Dental Services for Children with Neurodevelopmental Disorders
Key Mechanisms
Expansion of dental-care access and tailored services for children with neurodevelopmental disorders, including evidence-based models and innovative methods.
Target Population
Patients or participants described in the source article.
Care Setting
Care setting described in the source article.
Key Highlights
HRSA awarded $51 million to enhance dental services for children with neurodevelopmental disorders.
Funds will support preventive dental care and workforce enhancement in health centers.
Routine dental visits are challenging due to sensory sensitivities, anxiety, mobility challenges, and other factors.
Health centers will implement evidence-informed strategies for oral healthcare, including integration of oral health into comprehensive primary care.
The initiative aims to identify effective practices for replication in other communities.
Guideline-Based Recommendations
Diagnosis
Consider sensory sensitivities and other factors when diagnosing oral health needs.
Management
Expand and tailor preventive and other dental services for children with neurodevelopmental disorders.
Monitoring & Follow-up
Regular assessments of oral health status in children with neurodevelopmental disorders.
Risks
Higher risk of oral health problems such as tooth decay and gum disease.
Patient & Prescribing Data
Children with neurodevelopmental disorders.
Access to routine preventive dental care is crucial for maintaining oral health.
Clinical Best Practices
Integrate oral health into comprehensive primary care.
Provide care coordination, transportation, outreach, and education services.
Address sensory sensitivities and anxiety in dental care settings.
Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.
